This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Carefusion 303, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Abhishek Krishnan - Innovator in Fluid Pumping Technology
Introduction
Abhishek Krishnan is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of medical devices, particularly in the development of fluid pumping technologies. His innovative approach has led to the creation of a unique device that enhances the efficiency of intravenous (IV) fluid delivery.
Latest Patents
Abhishek holds a patent for a Reusable Fluid Pumping Device. This invention includes pump assemblies designed for use with an IV set. The pump assembly features a rotatable crank, a piston rod, and a diaphragm assembly. The crank is designed with a profile that defines multiple lobes, while the piston rod includes two followers spaced apart. The crank's rotation causes the piston rod to reciprocate, facilitating fluid movement. The diaphragm assembly, which includes a housing and a diaphragm member, is crucial for drawing in and expelling fluid from the IV set. This innovative design allows for efficient fluid management in medical applications.
Career Highlights
Abhishek is currently employed at Carefusion 303, Inc., where he continues to work on advancements in medical technology. His role involves collaborating with a team of professionals to develop innovative solutions that improve patient care.
Collaborations
Abhishek collaborates with his coworker, Karthik Mr., to further enhance the capabilities of their projects. Together, they strive to push the boundaries of medical device technology.
Conclusion
Abhishek Krishnan's contributions to fluid pumping technology exemplify the spirit of innovation in the medical field. His patent for a reusable fluid pumping device showcases his commitment to improving healthcare solutions. Through his work at Carefusion 303, Inc., he continues to make a positive impact on patient care.